Effects and Childbirth Experience Between Zhang and WHO Partograph

National University of Malaysia713 enrolled

Overview

This study compared the labour outcomes and childbirth experience between Zhang and WHO partograph.

A prospective cross-sectional observational study that compared the cervical os dilatation i.e 4 and 6 cm upon admission to the labour room. Eligible patients were recruited during postnatal period in the ward before discharged home. The details of clinical characteristics and labour outcomes were collected. Patients then answered the CEQ-My questionnaire form that assess their childbirth experiences. The primary outcome measure was caesarean section rate and the secondary outcome measure was the childbirth experience.

Study Type

OBSERVATIONAL

Enrollment

713

Conditions

Outcome, Adverse Birth Childbirth Experience

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * cervical dilatation 4 or 6 cm * singleton * cephalic presentation * at 37 weeks or more * normal cardiotocograph tracing on admission * understands Malay or English * no uterine scar * no pre-existing medical disorders * no antenatal complications such as diabetes or hypertension Exclusion Criteria: * multiple pregnancy * none cephalic presentation * abnormal admission cardiotocograph tracing * less than 37 weeks gestation * refusal to participate

Locations (1)

Hospital Canselor Tuanku Muhriz

Kuala Lumpur, Cheras, Malaysia

Outcomes

Primary Outcomes

Caesarean section rate

Rate of delivery via caesarean section in percentage

Time frame: from cervical dilatation of 4 or 6 cm through study completion up to delivery of the foetus

Secondary Outcomes

Childbirth experience

Assessment of experience during delivery using questionnaire based on based on total childbirth experience questionnaire score using Likert scale from 1 to 4. Score of 4 is a total agreement and score of 1 is total disagreement.

Time frame: from Day 1 throughout study completion, an average of 7 days after delivery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.